You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idiotype

Showing 1 - 25 of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023

Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Beijing (6B11-OCIK Injection, Doxorubicin)

Recruiting
  • Recurrent Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • Beijing, China
    Peking University People's hospital
Feb 11, 2022

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 2, 2019

Multiple Myeloma Trial in Brussels (Blood sampling and bone marrow analysis)

Completed
Has Results
  • Multiple Myeloma
  • Blood sampling and bone marrow analysis
  • Brussels, Belgium
    UZ Brussel
Oct 27, 2021

Neuroblastoma Trial in Pilar, Buenos Aires (Racotumomab)

Active, not recruiting
  • Neuroblastoma
  • Pilar, Buenos Aires, Argentina
  • +1 more
Sep 30, 2021

Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Dallas (biological, drug, radiation)

Withdrawn
  • Brain and Central Nervous System Tumors
  • +3 more
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +4 more
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Nov 21, 2018

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

NSCLC Trial in Seoul (CKD-702)

Recruiting
  • Non-Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 11, 2020

Lymphoma Trial in Omaha (autologous tumor cell vaccine, keyhole limpet hemocyanin, sargramostim)

Terminated
Has Results
  • Lymphoma
  • autologous tumor cell vaccine
  • +3 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Aug 2, 2018

The Research Registry for Neonatal Lupus

Recruiting
  • Neonatal Lupus
  • +3 more
  • No intervention; observational
  • New York, New York
    Jill P. Buyon, MD
Sep 6, 2022

Chronic Lymphocytic Leukemia- Binet Staging System Trial in Spain (Acalabrutinib 100 MG Oral Capsule)

Recruiting
  • Chronic Lymphocytic Leukemia- Binet Staging System
  • Acalabrutinib 100 MG Oral Capsule
  • A Coruña, Spain
  • +20 more
Jan 17, 2022

Lymphoma Trial (Id-KLH)

Completed
  • Lymphoma
  • Id-KLH
  • (no location specified)
Jan 13, 2018

Multiple Myeloma Trial in Philadelphia, Houston (CD3/CD28)

Completed
Has Results
  • Multiple Myeloma
  • CD3/CD28
  • Philadelphia, Pennsylvania
  • +1 more
Dec 2, 2020

Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker

Completed
  • Recurrent Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v7
  • Ipilimumab
  • +3 more
  • San Francisco, California
    UCSF Medical Center-Mount Zion
Jul 29, 2020

NSCLC Trial in Canada, United States (Nivolumab, Carboplatin, Paclitaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Baltimore, Maryland
  • +4 more
Jul 26, 2022

Neuroblastoma Trial in Worldwide (ch14.18/CHO, Aldesleukin, Isotretinoin)

Unknown status
  • Neuroblastoma
  • Vienna, Austria
  • +13 more
Jul 9, 2020

Lymphoma Trial in Omaha (keyhole limpet hemocyanin, sargramostim, tumor cell-based vaccine therapy)

Completed
  • Lymphoma
  • keyhole limpet hemocyanin
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 13, 2018

Lymphoma Trial in Stanford, Omaha (keyhole limpet hemocyanin, sargramostim, tumor cell-based vaccine therapy)

Completed
  • Lymphoma
  • keyhole limpet hemocyanin
  • +7 more
  • Stanford, California
  • +1 more
Jan 13, 2018

B Cell Lymphoma, Follicular Lymphoma, Tumor Trial run by the NCI (Id-KLH Vaccine, QS-21 (Stimulation-QS-21) Drug)

Completed
  • B Cell Lymphoma
  • +2 more
  • Id-KLH Vaccine
  • QS-21 (Stimulation-QS-21) Drug
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

B Cell Lymphoma, Follicular Lymphoma, Lymphoma Trial run by the NCI (Id-KLH Vaccine, GM-CSF)

Completed
  • B Cell Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Multiple Myeloma Trial run by the NCI (Myeloma Immunoglobulin Idiotype Vaccine, Bortezomib, Cyclophosphamide)

Completed
Has Results
  • Multiple Myeloma
  • Myeloma Immunoglobulin Idiotype Vaccine
  • +11 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 19, 2017

Toxic Shock Syndrome Trial in Bron (Intravenous human immunoglobulin, Albumin)

Completed
  • Toxic Shock Syndrome
  • Intravenous human immunoglobulin
  • Albumin
  • Bron, France
    Hôpital Femme Mère Enfant
Jun 7, 2021

Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)

Terminated
  • Multiple Sclerosis
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Apr 26, 2019

Leukemia, Lymphocytic, Chronic Trial in Houston (CLL vaccine using DNA plasmid vector)

Terminated
  • Leukemia, Lymphocytic, Chronic
  • CLL vaccine using DNA plasmid vector
  • Houston, Texas
    MD Anderson Cancer Center
Oct 30, 2018

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (drug, procedure,

Withdrawn
  • Fallopian Tube Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 12, 2017